Clinical Role - Hospital
Pharmacy Times® is at the forefront of providing the latest clinical updates, patient counseling tools and innovative solutions to hospital pharmacists and reaches more than 200,000 pharmacy professionals in total.
The panel of experts review the monitoring parameters for determining efficacy of DOACs.
Conduct proper review and evaluation of ARV and DOAC pharmacokinetics and metabolism prior to recommending treatment.
Proposed CMS changes could hurt many health systems that are already struggling due to COVID-19 pandemic.
Study also highlights transitions-of-care programs that help patients avoid ED visits or acute care stays.
Maximizer programs are likely to lead to the dwindling or death of PAPs as we know them.
Asembia offers a complete ecosystem of products and services focused on financial solutions and contracting programs to the specialty pharmacy market.
Asembia is the industry’s leading group purchasing organization (GPO) focused on the specialty pharmacy market.
It is especially important to better understand the interactions between COVID-19 and acute respiratory distress syndrome.
As we head into flu season, count on Directions in Health-System Pharmacy™ to continue to report on the latest developments on COVID-19.
Experts discuss the recommendation in monitoring when using DOACs.
The panel of experts in cardiology discuss the barriers with treatment of obese patients with DOACs. They also discuss the importance of education of their peers.
This week’s pharmacy management Tip of the Week takes a look at establishing a clinical pharmacy site in the emergency department (ED) of a hospital.
There is a new study that discovered certain drugs cause problems in healthy people who do not have risk factors or family members with dementia.